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Going  smoke-free
1  from  the  Tobacco
Advisory Group of the Royal College of
Physicians presents a well thought out and
documented  approach  to  the  “medical
case”  for  establishing  smoke-free
environments at home, work, and in public
areas.   It addresses the medical evidence
and present a convincing argument in favor
of  smoke-free  policy.   The  authors
conclude  from  their  information  that
enacting  “legislation  to  make  all
workplaces and public spaces smoke-free”
should be pursued as quickly as possible
citing many medical benefits as well as
economic  spin-offs  and  public  support.
However, it is not medical concerns that
directly stimulate passage of legislation but
rather  political  concerns,  which  are
informed by medical, as well as practical,
social,  economic  and  ethical  issues.
Therefore Going Smoke Free devotes the
first  four  chapters  specifically  to  the
medical  case  for  legislation  supporting
smoke-free environments.  These address a
comprehensive array of medical conditions
that appear to be related in one manner or
another to environmental tobacco smoke
(ETS).  The  remaining  chapters  provide
interesting  information  and  compelling
arguments in favor of smoke-free policies
that  support  the  political  case  for
legislation  and  address  many  of  the
tobacco  industry’s  tactics  to  negate  the
anti-smoking criticisms they have endured
in the recent past.  Going smoke free is a
comprehensive  primer  that  balances
critical analyses of the evidence in a format
that  is  concise  and  accessible.   The
discussions are well cited, and the lists of
references  alone  will  be  resources  to
advocates of smoke-free policy.
This  publication  from  the  Royal
College  of  Physicians  brings  together
substantial epidemiological research from
several countries providing the evidence
that  overwhelmingly  supports  the
institution of smoke-free policies.   While
many  studies  have  shown  that  direct
smoking induces a wide array of health
problems,  few  other  all-encompassing
works are available particularly related to
second  hand  smoke  exposure.
Environmental  tobacco  smoke  exposure
has been studied sufficiently over the last
few years for links between ETS and a
number of diseases to be evident.   ETS
increases by between 20 and 40 percent the
risk of developing lung cancer, ischaemic
heart disease, COPD, and stroke.   Going
smoke-free  applies  to  these  data  a
published statistical model to estimate the
number  of  deaths  from  the  above  four
diseases  that  can  be  attributed  to  ETS
exposure, and they estimate that almost
500 deaths per year can be attributed solely
to ETS exposure in the workplace.
Total  smoking  restrictions  and
smoke-free policies that are in place are
shown to be effective at almost eliminating
exposure  to  ETS  in  the  workplace  and
public spaces.   One study in New York
City  showed  an  average  decrease  in
respiratory  suspended  particles  of  93
percent in a variety of bars and restaurants
following the city’s total indoor smoking
ban.   Another  study  from  Helena,
Montana, suggests that six months into a
smoking  ban,  a  reduction  in  hospital4 REVIEW – Hawkins S
admissions for myocardial infarction for
residents who worked and lived inside the
city had occurred, whereas there was no
corresponding decrease in admissions from
the group who lived outside of the city.
The  British  public  appears
appraised of the dangers of ETS exposure,
with 8 of 10 people agreeing that breathing
someone else’s smoke increases their risk
of  lung  cancer,  bronchitis,  and  asthma.
This likely contributes to the high public
support for smoke-free legislation among
the British public.  A Philip Morris study
from as early as 1989 suggested that 70
percent of adults in the UK believe the
government should pass laws restricting
smoking in public places.  Today support
lies above 80 percent, though it is less for
smoking restrictions in pubs.  The evidence
from extant smoking bans in the US and
Ireland indicate that their implementation
can be met with widespread public support.
In Ireland after implementation of smoking
restrictions in pubs almost 50% of smokers
support such a ban compared to very low
levels prior to activation.
The  case  for  smoke-free  policies
should  be  sufficient  to  spur  passage  of
legislation.  However, the debate is heavily
influenced by the tobacco industry, which
is keen to prevent passage of legislation.
Going  smoke-free  devotes  a  very
interesting chapter to the history of the
tobacco  industry’s  involvement  in  the
debate over smoke-free policies, detailing
the  tactics  used  to  dilute  and  divert
attention from the strong case in favor of
total smoking bans.  The industry’s tactics
include  enflaming  merchants’  and
governments’  fears  of  dire  economic
consequences, sponsoring groups to lobby
for  “smokers’  rights”,  and  sponsoring
scientific groups to challenge the evidence
for links between ETS and disease.  Going
smoke-free addresses each of these claims
and  rhetorical  tricks  of  the  tobacco
industry.  The discussion of the lobby for
“smokers’  rights”  while  not  extensive
provides  some  ethical  balance  in
addressing  the  dilemma  of  these  rights
versus non-smokers’ rights to clean air.
Ethical and civil-liberties arguments of the
concept of smokers’ rights are unpacked,
and skillfully disputed.  Two chapters are
devoted to the economic impact of smoke-
free policy, one of which is devoted to its
effect on the hospitality industry (pubs and
restaurants)  and  disputes  the  recurring
claims that smoking bans have negative
economic  consequences.   An  excellent
discussion  is  also  included  of  how  the
scientific  literature  is  appraised  by  the
tobacco  industry  and  its  attempts  to
suggest that what has been done to date is
not “sound science”.  Opponents of smoke-
free legislation exploit this fact, posing
irresponsible challenges to the scientific
evidence, making sweeping claims that the
evidence is not yet clear, and based on
isolated studies, ETS is innocuous.   It is
true that biases affect claims made about
particular studies, but those biases can both
over- and underestimate the link between
ETS  and  disease.   Claims  about  the
scientific  evidence  must  be  made  by
appraising  the  full  body  of  research
performed on a particular topic, something
aided  by  the  publishing  of  systemic
overviews and meta-reviews.   Overviews
that critique the available literature in its
entirety are a far more reliable indicator
than the results of single studies.   Indeed
an excellent example of the latter are the is
the consistent findings of relative risks for
developing lung cancer in never-smokers
exposed to ETS.
With  the  existing  and  pending
comprehensive smoke-free legislation in
the UK, the tobacco industry will continue
to  attempt  to  thwart  and  dilute  the
legislation.   For those wishing to see the
full  implementation  of  smoke-free
legislation in the UK, and for other nations
considering  the  passage  of  smoke-free
legislation,  this  book  is  an  invaluable
resource.
1 “Going smoke-free.   The medical case for clean
air in the home, at work and in public places.” A
report  on  passive  smoking  by  the  Tobacco
Advisory  Group  of  the  Royal  College  of
Physicians. July 2005. RCP Publications ISBN 1
86016 246 0. www.rcplondon.ac.uk.